SEC 13F Intelligence

Dekabank Deutsche Girozentrale / CVS

Dekabank Deutsche Girozentrale’s Cvs Health Corp Position

Does Dekabank Deutsche Girozentrale own Cvs Health Corp (CVS)? Yes — 1.86M shares worth $133M (+0.22% of its 13F portfolio) as of Q1 2026.

Position Value
$133M
Q1 2026
Shares
1.86M
% of Portfolio
+0.22%
Quarters Held
28
currently held

Position History CVS

Reported value by quarter
Q1 ’19: $49MQ1 ’19Q2 ’19: $33MQ3 ’19: $83MQ4 ’19: $115MQ1 ’20: $104MQ1 ’20Q2 ’20: $115MQ3 ’20: $115MQ1 ’21: $137MQ2 ’21: $138MQ2 ’21Q3 ’21: $144MQ4 ’21: $190MQ1 ’22: $195MQ2 ’22: $144MQ2 ’22Q3 ’22: $165MQ4 ’22: $168MQ1 ’23: $147MQ2 ’23: $166MQ2 ’23Q3 ’23: $126MQ4 ’23: $140MQ1 ’24: $150MQ2 ’24: $34MQ2 ’24Q3 ’24: $114MQ4 ’24: $82MQ1 ’25: $127MQ2 ’25: $127MQ2 ’25Q3 ’25: $140MQ4 ’25: $137MQ1 ’26: $133Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.86M$133M+0.22%
Q4 20251.86M$137M+0.24%
Q3 20251.86M$140M+0.24%
Q2 20251.86M$127M+0.23%
Q1 20251.90M$127M+0.25%
Q4 20241.86M$82M+0.15%
Q3 20241.86M$114M+0.21%
Q2 2024575.6K$34M+0.06%
Q1 20241.90M$150M+0.28%
Q4 20231.77M$140M+0.29%
Q3 20231.80M$126M+0.29%
Q2 20232.41M$166M+0.37%
Q1 20231.97M$147M+0.37%
Q4 20221.81M$168M+0.44%
Q3 20221.71M$165M+0.49%
Q2 20221.56M$144M+0.42%
Q1 20221.88M$195M+0.48%
Q4 20211.82M$190M+0.46%
Q3 20211.65M$144M+0.40%
Q2 20211.66M$138M+0.40%
Q1 20211.81M$137M+0.46%
Q3 20202.02M$115M+0.51%
Q2 20201.79M$115M+0.72%
Q1 20201.73M$104M+0.80%
Q4 20191.55M$115M+0.70%
Q3 20191.34M$83M+0.52%
Q2 2019603.3K$33M+0.17%
Q1 2019653.7K$49M+0.29%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dekabank Deutsche Girozentrale’s full portfolio or all institutional holders of CVS.